Predictors of Motor İmagery Performance in Cerebral Palsy

NCT07002567 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2025-07-04

No results posted yet for this study

Summary

There are very few studies in the literature examining the effect of age on motor imagery ability in children with cerebral palsy. To our knowledge, no studies have investigated the impact of other related factors. The aim of this study is to investigate the effects of age, sex, body mass index, Gross Motor Function Classification System (GMFCS) level, and Manual Ability Classification System (MACS) level on motor imagery abilities in children with cerebral palsy.

H1-1: Age has an effect on motor imagery abilities in children with cerebral palsy.

H1-2: Sex has an effect on motor imagery abilities in children with cerebral palsy.

H1-3: Clinical type has an effect on motor imagery abilities in children with cerebral palsy.

H1-4: Body mass index has an effect on motor imagery abilities in children with cerebral palsy.

H1-5: GMFCS level has an effect on motor imagery abilities in children with cerebral palsy.

H1-6: MACS level has an effect on motor imagery abilities in children with cerebral palsy.

Conditions

  • Cerebral Palsy (CP)
  • Spasticity
  • Motor Learning

Interventions

OTHER

Implicit motor imagery

Implicit motor imagery is the ability to engage with the projection and manipulation of the body schema from a first-person perspective. Implicit motor imagery skills were evaluated Recognize App Recognize Hand Hand Laterality Task with, developed by NOI group. (http://www.noigroup.com/ Recognise).

OTHER

Explicit motor imagery

In explicit motor imagery, the person simulates a specific motor movement, that is, the individual is aware that she is imagining the movement.Explicit motor imagery skills were evaluated with Movement Imagery Questionnaire for Children (MIQ-C), mental chronometry and box block test.

Sponsors & Collaborators

  • Abant Izzet Baysal University

    lead OTHER

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-04
Primary Completion
2025-09-01
Completion
2025-11-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07002567 on ClinicalTrials.gov